Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |